Log in

Coordinatized lesion location analysis empowering ROI-based radiomics diagnosis on brain gliomas

  • Oncology
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To assess the value of coordinatized lesion location analysis (CLLA), in empowering ROI-based imaging diagnosis of gliomas by improving accuracy and generalization performances.

Methods

In this retrospective study, pre-operative contrasted T1-weighted and T2-weighted MR images were obtained from patients with gliomas from three centers: **ling Hospital, Tiantan Hospital, and the Cancer Genome Atlas Program. Based on CLLA and ROI-based radiomic analyses, a fusion location-radiomics model was constructed to predict tumor grades, isocitrate dehydrogenase (IDH) status, and overall survival (OS). An inter-site cross-validation strategy was used for assessing the performances of the fusion model on accuracy and generalization with the value of area under the curve (AUC) and delta accuracy (ACC) (ACCtesting—ACCtraining). Comparisons of diagnostic performances were performed between the fusion model and the other two models constructed with location and radiomics analysis using DeLong’s test and Wilcoxon signed ranks test.

Results

A total of 679 patients (mean age, 50 years ± 14 [standard deviation]; 388 men) were enrolled. Based on tumor location probabilistic maps, fusion location-radiomics models (averaged AUC values of grade/IDH/OS: 0.756/0.748/0.768) showed the highest accuracy in contrast to radiomics models (0.731/0.686/0.716) and location models (0.706/0.712/0.740). Notably, fusion models ([median Delta ACC: − 0.125, interquartile range: 0.130]) demonstrated improved generalization than that of radiomics model ([− 0.200, 0.195], p = 0.018).

Conclusions

CLLA could empower ROI-based radiomics diagnosis of gliomas by improving the accuracy and generalization of the models.

Clinical relevance statement

This study proposed a coordinatized lesion location analysis for glioma diagnosis, which could improve the performances of the conventional ROI-based radiomics model in accuracy and generalization.

Key Points

• Using coordinatized lesion location analysis, we mapped anatomic distribution patterns of gliomas with specific pathological and clinical features and constructed glioma prediction models.

• We integrated coordinatized lesion location analysis into ROI-based analysis of radiomics to propose new fusion location-radiomics models.

• Fusion location-radiomics models, with the advantages of being less influenced by variabilities, improved accuracy, and generalization performances of ROI-based radiomics models on predicting the diagnosis of gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

AUC:

Area under the curve

HGG:

High-grade glioma

IDH:

Isocitrate dehydrogenase

LGG:

Low-grade glioma

OS:

Overall survival

ROI:

Region-of-interest

TCGA:

The Cancer Genome Atlas

WHO:

World Health Organization

References

  1. Low JT, Ostrom QT, Cioffi G et al (2022) Primary brain and other central nervous system tumors in the United States (2014–2018): a summary of the CBTRUS statistical report for clinicians. Neurooncol Pract 9:165–182

    PubMed  PubMed Central  Google Scholar 

  2. Germann J, Zadeh G, Mansouri A, Kucharczyk W, Lozano AM, Boutet A (2022) Untapped Neuroimaging Tools for Neuro-Oncology: Connectomics and Spatial Transcriptomics. Cancers 14:464

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Hu LS, Hawkins-Daarud A, Wang LJ, Li J, Swanson KR (2020) Imaging of intratumoral heterogeneity in high-grade glioma. Cancer Lett 477:97–106

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Boonzaier NR, Larkin TJ, Matys T, van der Hoorn A, Yan JL, Price SJ (2017) Multiparametric MR imaging of diffusion and perfusion in contrast-enhancing and nonenhancing components in patients with glioblastoma. Radiology 284:180–190

    PubMed  Google Scholar 

  5. Bette S, Huber T, Gempt J et al (2017) Local fractional anisotropy is reduced in areas with tumor recurrence in glioblastoma. Radiology 283:499–507

    PubMed  Google Scholar 

  6. Karaman MM, Zhang JX, **e KL, Zhu WZ, Zhou XHJ (2021) Quartile histogram assessment of glioma malignancy using high b-value diffusion MRI with a continuous-time random-walk model. NMR Biomed 34:e4485

    CAS  PubMed  Google Scholar 

  7. Zhang S, Chiang GCY, Magge RS et al (2019) Texture analysis on conventional MRI images accurately predicts early malignant transformation of low-grade gliomas. Eur Radiol 29:2751–2759

    PubMed  Google Scholar 

  8. Tomaszewski MR, Gillies RJ (2021) The biological meaning of radiomic features. Radiology 298:505–516

    PubMed  Google Scholar 

  9. Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577

    PubMed  Google Scholar 

  10. Le NQK, Hung TNK, Do DT, Lam LHT, Dang LH, Huynh TT (2021) Radiomics-based machine learning model for efficiently classifying transcriptome subtypes in glioblastoma patients from MRI. Comput Biol Med 132:104320

    CAS  PubMed  Google Scholar 

  11. Sudre CH, Panovska-Griffiths J, Sanverdi E et al (2020) Machine learning assisted DSC-MRI radiomics as a tool for glioma classification by grade and mutation status. BMC Med Inform Decis Mak 20:149

    PubMed  PubMed Central  Google Scholar 

  12. Malik N, Geraghty B, Dasgupta A et al (2021) MRI radiomics to differentiate between low grade glioma and glioblastoma peritumoral region. J Neurooncol 155:181–191

    PubMed  Google Scholar 

  13. Li YM, Wei D, Liu X et al (2022) Molecular subty** of diffuse gliomas using magnetic resonance imaging: comparison and correlation between radiomics and deep learning. Eur Radiol 32:747–758

    PubMed  Google Scholar 

  14. Kim M, Jung SY, Park JE et al (2020) Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma. Eur Radiol 30:2142–2151

    PubMed  Google Scholar 

  15. Choi YS, Bae S, Chang JH et al (2021) Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics. Neuro Oncol 23:304–313

    CAS  PubMed  Google Scholar 

  16. Zhuo ZZ, Qu LY, Zhang P et al (2021) Prediction of H3K27M-mutant brainstem glioma by amide proton transfer-weighted imaging and its derived radiomics. Eur J Nucl Med Mol Imaging 48:4426–4436

    CAS  PubMed  Google Scholar 

  17. Lam LHT, Do DT, Diep DTN et al (2022) Molecular subtype classification of low-grade gliomas using magnetic resonance imaging-based radiomics and machine learning. NMR Biomed 35:e4792

    CAS  PubMed  Google Scholar 

  18. Yan J, Zhaoc YS, Chend YS et al (2021) Deep learning features from diffusion tensor imaging improve glioma stratification and identify risk groups with distinct molecular pathway activities. EBioMedicine 72:103583

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Vajapeyam S, Brown D, Billups C et al (2020) Advanced ADC histogram, perfusion, and permeability metrics show an association with survival and pseudoprogression in newly diagnosed diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium. AJNR Am J Neuroradiol 41:718–724

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Vecchio TG, Neimantaite A, Corell A et al (2021) Lower-grade gliomas: an epidemiological voxel-based analysis of location and proximity to eloquent regions. Front Oncol 11:748229

    Google Scholar 

  21. Fyllingen EH, Bo LE, Reinertsen I et al (2021) Survival of glioblastoma in relation to tumor location: a statistical tumor atlas of a population-based cohort. Acta Neurochir 163:1895–1905

    PubMed  Google Scholar 

  22. Steed TC, Treiber JM, Taha B et al (2020) Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state. J Neurooncol 148:455–462

    CAS  PubMed  Google Scholar 

  23. Cardinale F, Cossu M, Castana L et al (2013) Stereoelectroencephalography: surgical methodology, safety, and stereotactic application accuracy in 500 procedures. Neurosurgery 72:353–366

    PubMed  Google Scholar 

  24. Fan X, Wang YY, Liu Y et al (2016) Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas. J Neurooncol 128:455–462

    CAS  PubMed  Google Scholar 

  25. Liu TT, Achrol AS, Mitchell LA et al (2016) Computational identification of tumor anatomic location associated with survival in 2 large cohorts of human primary glioblastomas. AJNR Am J Neuroradiol 37:621–628

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Neyra MAT, Neuberger U, Reinhardt A et al (2018) Voxel-wise radiogenomic map** of tumor location with key molecular alterations in patients with glioma. Neuro Oncol 20:1517–1524

    CAS  Google Scholar 

  27. Tang QS, Lian YX, Yu JH, Wang YY, Shi ZF, Chen L (2017) Anatomic map** of molecular subtypes in diffuse glioma. BMC Neurol 17:183

    PubMed  PubMed Central  Google Scholar 

  28. Yunhe M, Yuan Y, ** seizure foci and tumor genetic factors in glioma associated seizure patients. J Neurosurg Sci 64:456–463

    PubMed  Google Scholar 

  29. Ellingson BM, Lai A, Harris RJ et al (2013) Probabilistic radiographic atlas of glioblastoma phenotypes. AJNR Am J Neuroradiol 34:533–540

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Zwanenburg A, Vallieres M, Abdalah MA et al (2020) The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenoty**. Radiology 295:328–338

    PubMed  Google Scholar 

  31. Meyer M, Ronald J, Vernuccio F et al (2019) Reproducibility of CT radiomic features within the same patient: influence of radiation dose and CT reconstruction settings. Radiology 293:583–591

    PubMed  Google Scholar 

  32. Berenguer R, Pastor-Juan MD, Canales-Vazquez J et al (2018) Radiomics of CT features may be nonreproducible and redundant: influence of CT acquisition parameters. Radiology 288:407–415

    PubMed  Google Scholar 

  33. Mazziotta J, Toga A, Evans A et al (2001) A probabilistic atlas and reference system for the human brain: International Consortium for Brain Map** (ICBM). Philos Trans R Soc Lond B Biol Sci 356:1293–1322

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Brett M, Leff AP, Rorden C, Ashburner J (2001) Spatial normalization of brain images with focal lesions using cost function masking. Neuroimage 14:486–500

    CAS  PubMed  Google Scholar 

  35. Wu D, Ma T, Ceritoglu C et al (2016) Resource atlases for multi-atlas brain segmentations with multiple ontology levels based on T1-weighted MRI. Neuroimage 125:120–130

    PubMed  Google Scholar 

  36. Segato A, Marzullo A, Calimeri F, De Momi E (2020) Artificial intelligence for brain diseases: a systematic review. APL Bioeng 4:041503

    PubMed  PubMed Central  Google Scholar 

  37. van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:e104–e107

    PubMed  PubMed Central  Google Scholar 

  38. Hu XF, Gong J, Zhou W et al (2021) Computer-aided diagnosis of ground glass pulmonary nodule by fusing deep learning and radiomics features. Phys Med Biol 66:065015

    PubMed  Google Scholar 

  39. Li A, Zalesky A, Yue WH et al (2020) A neuroimaging biomarker for striatal dysfunction in schizophrenia. Nat Med 26:558–565

    CAS  PubMed  Google Scholar 

  40. Delong ER, Delong DM, Clarkepearson DI (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845

    CAS  PubMed  Google Scholar 

  41. Müller DMJ, Robe PA, Ardon H et al (2020) Quantifying eloquent locations for glioblastoma surgery using resection probability maps. J Neurosurg 134:1091–1101

    PubMed  Google Scholar 

  42. Roux A, Roca P, Edjlali M et al (2019) MRI Atlas of IDH wild-type supratentorial glioblastoma: probabilistic maps of phenotype, management, and outcomes. Radiology 293:633–643

    PubMed  Google Scholar 

  43. Lim DA, Cha S, Mayo MC et al (2007) Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 9:424–429

    PubMed  PubMed Central  Google Scholar 

  44. Park CJ, Han K, Kim H et al (2020) Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas. Eur Radiol 30:6464–6474

    CAS  PubMed  Google Scholar 

  45. Nakamoto T, Takahashi W, Haga A et al (2020) Prediction of malignant glioma grades using contrast-enhanced T1-weighted and T2-weighted magnetic resonance images based on a radiomic analysis. Sci Rep 9:19411

    Google Scholar 

Download references

Acknowledgements

Thanks are due to John W Chen from the Massachusetts General Hospital, Harvard Medical School for the revision of our manuscript.

Funding

This study has received funding by grants from the National Key Technology (R&D) Program of the Ministry of Science and Technology (2018YFA0701703 to Zhiqiang Zhang); the National Science and Technology Innovation 2030 − Major program of “Brain Science and Brain-Like Research” (2022ZD0211800 to Zhiqiang Zhang); Xuzhou Medical University Open Fund Project (XYKF202101 to Zhiqiang Zhang); the National Key R&D Program of China (2020AAA0109505 to Guangming Lu); and the National Natural Science Foundation of China (82127806 to Guangming Lu).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhiqiang Zhang.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Zhiqiang Zhang from the Department of Diagnostic Radiology, Affiliated **ling Hospital, Medical School of Nan**g University.

Conflict of interest

Qing Zhou and Feng Shi are employees of Shanghai United Imaging Intelligence Co., Ltd. The company has no role in designing and performing the surveillance and analyzing and interpreting the data. The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

Mengjie Lu from the School of Public Health, Shanghai Jiaotong University School of Medicine, is one of the authors who has significant statistical expertise.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• retrospective

• cross-sectional study

• multicenter study

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 859 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, X., Zhang, Q., Li, J. et al. Coordinatized lesion location analysis empowering ROI-based radiomics diagnosis on brain gliomas. Eur Radiol 33, 8776–8787 (2023). https://doi.org/10.1007/s00330-023-09871-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-09871-y

Keywords

Navigation